ICICI Securities Ltd.
Jefferies India Pvt.Ltd.
JM Financial Ltd.
Motilal Oswal Investment Advisors Ltd.
Founded in 2015, Turtlemint Limited is a technology-driven insurance distribution platform operating on a “phygital” model that bridges the gap between consumers, insurers, and digital advisors. As a pioneer in adopting the Point-of-Sale Person (PoSP) framework, the company has successfully scaled India’s largest certified PoSP network. Through its proprietary app, Turtlemint Pro, the platform empowers over 6.32 lakh Digital Partners to seamlessly compare, recommend, and distribute life, health, and motor insurance products from 45 premier insurance partners.
By strategically focusing on underserved B30 markets, Turtlemint has extended its operational footprint to cover nearly 98% of India’s pin codes. Between April 2022 and December 2025, the company facilitated the issuance of over 21.87 million policies, generating a platform premium exceeding ₹10,066 crore. Leveraging AI-driven insights and mobile-first infrastructure, Turtlemint continues to enhance consumer experience while significantly accelerating insurance penetration across the nation.
For the year/period ended (Rs. in Cr.)
| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Total Revenue | 693.21 | 119.12 | 460.11 |
| Profit After Tax | (194.11) | (193.35) | (288.18) |
| EPS | (7.33) | (7.30) | (11.16) |
| EBITDA Margin (%) | 11.89 | – | – |
| PAT Margin (%) | (28) | (162.32) | (62.63) |
For year/ period ended ( in Cr.)
| Company Name | Market Cap (Cr.) | Price | P/BV | P/E | Sales (Cr.) FY25 |
Net Profits(Cr.) FY25 |
|---|---|---|---|---|---|---|
| Turtlemint Fintech Solutions Limited | 3852* | 152 | 0.02 | – | 693.21 | (194.11) |
| PB Fintech Limited | 73328 | 1585 | 9.98 | 109 | 4977 | 353 |
*Market cap @upper band
The Company TURTLEMINT FINTECH SOLUTIONS IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
At the upper band of IPO Rs. 152, the stock is valued at a negative P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.